Pylum Biosciences, Inc.
San Carlos, CA
- UEI
- LLANDDLF1151
- CAGE
- 882C4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 733 Industrial Rd, San Carlos, CA 94070, USA
- Website
- pylumbio.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of modified r-type bacteriocins to specifically target c. Difficile and prevent relapse of cdis | National Institute of Allergy and Infectious Diseases (NIH) | $1,307,122 |
SBA capabilities narrative
Pylum Biosciences has developed and patented the Avidocin platform technology, capable of generating batericidal protein complexes targeting specfic bacterial pathogens using a unique killing mechanism that is oblivious to CRISPR based resistance. Avidocin proteins can be quickly modified to kill emerging strains as their genome sequences become available. Our pipeline is focused on infectious diseases (eg C. diff) and oncology related pathogens (eg CRC).
Quick answers
Is Pylum Biosciences, Inc. registered in SAM.gov?
Yes. Pylum Biosciences, Inc.'s SAM.gov registration is active through March 5, 2027.
What is Pylum Biosciences, Inc.'s most recent federal award?
Pylum Biosciences, Inc.'s most recent federal grant award is Development of modified r-type bacteriocins to specifically target c. Difficile and prevent relapse of cdis (R33AI121692), from National Institute of Allergy and Infectious Diseases (NIH), on December 1, 2015.
On GovTribe
See Pylum Biosciences, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors